Author

S. E. Brightman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. L. R. Premlal· 1 shared B. Peters· 1 shared E. E. W. Cohen· 1 shared J. A. Greenbaum· 1 shared J. Lee· 1 shared J. S. Dolina· 1 shared M. Lanka· 1 shared R. R. Thota· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. L. R. Premlal

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression

J. S. Dolina, J. Lee, S. E. Brightman, S. McArdle, S. M. Hall, R. R. Thota, M. Lanka, A. L. R. Premlal, J. A. Greenbaum, E. E. W. Cohen, B. Peters, S. P. Schoenberger

This study shows that combining CD4+/CD8+ T cell neoantigen vaccination with immune checkpoint blockade overcomes resistance and enables tumor regression in low TMB cancers.

bioRxiv · May 6, 2023 · PreprintImmunology